Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
David M. Stout Joins NanoBio Corporation's Board of Directors
June 11th, 2008
NanoBio(R) Corporation, a biopharmaceutical company focused on developing and commercializing novel products for the prevention and treatment of infectious diseases, announced the appointment of David M. Stout to its Board of Directors. Mr. Stout most recently served as President of Pharmaceutical Operations for GlaxoSmithKline Pharmaceuticals. "We are pleased to welcome David to our Board of Directors and look forward to benefiting from his guidance and contributions," said James R. Baker Jr., M.D., chairman of NanoBio Corporation. "David's 30-plus years of experience in all facets of the pharmaceutical industry -- including his recent experience as head of global...
Source: Vaccine Weekly (2008-06-11)
|
